Project Updates

EyePoint Pharmaceuticals

 Credit: Gorman Richardson Lewis Architects.

Location: Northbridge, Massachusetts, US
Project type: Manufacturing facility
Announced: January 2024
Expected Completion: H2 2024

EyePoint Pharmaceuticals, a US-based pharmaceutical company, will expand its laboratory and manufacturing capabilities with the construction of a new, custom-built commercial manufacturing facility. The facility will support the global production of the company’s programmes.


 Credit: Business Wire.

Location: Rockville, Maryland, US
Project type: Manufacturing facility
Announced: February 2024
Estimated Investment: $300m

AstraZeneca, a biopharmaceutical company based in the UK, will build an advanced manufacturing facility in Rockville, Maryland, US, to launch its life-saving cell therapy platforms in the US, which are essential for critical cancer trials and future commercial supply.



Location: Rockville, Maryland
Project type:  R&D facility
Investment: $65m
Opened: June 2022

Regenxbio built a research and development facility, which it calls the Manufacturing Innovation Center, in Montgomery County in Rockville, Maryland, US. The facility will provide the company with complete control over the entire gene therapy manufacturing process in Montgomery County.